Our data also show that, in Suit-2 cells, cyclin D1 levels are unaffected by K-Ras depletion, therefore the transcriptional activation of cyclin D1 by K-Ras is probably of little importance in an established tumour. This evidence concerns the gene KRAS and neoplasm.